MedTrace Logo

Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3

NCT05426408 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2025-03-10

No results posted yet for this study

Summary

The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding adenosine to the CMR investigation. Patient will be their own controls.

Conditions

  • Myocardial Infarction with Nonobstructive Coronary Arteries

Interventions

DIAGNOSTIC_TEST

Cardiac magnetic resonance imaging to study coronary microvascular dysfunction

Myocardial perfusion mapping will be investigated after administration of adenosine

Sponsors & Collaborators

Principal Investigators

  • Per Tornvall, MD · Karolinska Instítutet

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2025-12-31
Completion
2026-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05426408 on ClinicalTrials.gov